vs

Side-by-side financial comparison of Connect Biopharma Holdings Ltd (CNTB) and Hyperscale Data, Inc. (GPUS). Click either name above to swap in a different company.

Hyperscale Data, Inc. is the larger business by last-quarter revenue ($26.9M vs $24.1M, roughly 1.1× Connect Biopharma Holdings Ltd). Connect Biopharma Holdings Ltd runs the higher net margin — 61.6% vs -112.0%, a 173.5% gap on every dollar of revenue.

Connect Biopharma Holdings Ltd is a clinical-stage global biopharmaceutical company dedicated to developing innovative targeted therapies for inflammatory, immunological and autoimmune diseases. Its core pipeline includes candidate treatments for asthma, atopic dermatitis and other conditions with high unmet medical needs, with main operations across the U.S., China and key global markets to deliver effective therapeutic solutions to patients.

Hyperscale Data, Inc. provides GPU-accelerated computing infrastructure and cloud solutions tailored for AI development, big data processing, and high-performance computing workloads. It primarily serves AI startups, large technology firms, and cloud service providers across North America and the Asia-Pacific region, delivering scalable, high-efficiency computing resources to support complex data processing needs.

CNTB vs GPUS — Head-to-Head

Bigger by revenue
GPUS
GPUS
1.1× larger
GPUS
$26.9M
$24.1M
CNTB
Higher net margin
CNTB
CNTB
173.5% more per $
CNTB
61.6%
-112.0%
GPUS

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CNTB
CNTB
GPUS
GPUS
Revenue
$24.1M
$26.9M
Net Profit
$14.8M
$-30.1M
Gross Margin
14.5%
Operating Margin
56.6%
-117.8%
Net Margin
61.6%
-112.0%
Revenue YoY
38.4%
Net Profit YoY
148.7%
-6670.3%
EPS (diluted)
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTB
CNTB
GPUS
GPUS
Q4 25
$26.9M
Q3 25
$24.3M
Q2 25
$25.9M
Q1 25
$25.0M
Q4 24
$19.4M
Q3 24
$31.1M
Q2 24
$24.1M
$17.8M
Q1 24
$38.4M
Net Profit
CNTB
CNTB
GPUS
GPUS
Q4 25
$-30.1M
Q3 25
$-13.0M
Q2 25
$-19.1M
Q1 25
$-4.2M
Q4 24
$-445.0K
Q3 24
$-25.5M
Q2 24
$14.8M
$-33.9M
Q1 24
$3.7M
Gross Margin
CNTB
CNTB
GPUS
GPUS
Q4 25
14.5%
Q3 25
25.8%
Q2 25
23.7%
Q1 25
21.1%
Q4 24
6.5%
Q3 24
27.5%
Q2 24
-21.3%
Q1 24
47.4%
Operating Margin
CNTB
CNTB
GPUS
GPUS
Q4 25
-117.8%
Q3 25
-57.8%
Q2 25
-39.2%
Q1 25
-25.5%
Q4 24
-46.8%
Q3 24
-79.2%
Q2 24
56.6%
-151.4%
Q1 24
9.5%
Net Margin
CNTB
CNTB
GPUS
GPUS
Q4 25
-112.0%
Q3 25
-53.5%
Q2 25
-73.7%
Q1 25
-16.8%
Q4 24
-2.3%
Q3 24
-82.3%
Q2 24
61.6%
-190.7%
Q1 24
9.7%
EPS (diluted)
CNTB
CNTB
GPUS
GPUS
Q4 25
Q3 25
$-0.39
Q2 25
$-2.66
Q1 25
Q4 24
$-8.78
Q3 24
$-24.82
Q2 24
$0.27
$-37.81
Q1 24
$3.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTB
CNTB
GPUS
GPUS
Cash + ST InvestmentsLiquidity on hand
$110.2M
$13.1M
Total DebtLower is stronger
$83.1M
Stockholders' EquityBook value
$110.9M
$119.8M
Total Assets
$120.6M
$313.7M
Debt / EquityLower = less leverage
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTB
CNTB
GPUS
GPUS
Q4 25
$13.1M
Q3 25
$24.8M
Q2 25
$5.9M
Q1 25
$4.2M
Q4 24
$4.5M
Q3 24
$7.9M
Q2 24
$110.2M
$9.6M
Q1 24
$18.9M
Total Debt
CNTB
CNTB
GPUS
GPUS
Q4 25
$83.1M
Q3 25
$80.0M
Q2 25
$88.5M
Q1 25
$92.8M
Q4 24
$96.7M
Q3 24
$104.8M
Q2 24
$106.8M
Q1 24
$30.0M
Stockholders' Equity
CNTB
CNTB
GPUS
GPUS
Q4 25
$119.8M
Q3 25
$55.9M
Q2 25
$5.5M
Q1 25
$6.3M
Q4 24
$8.6M
Q3 24
$2.7M
Q2 24
$110.9M
$26.7M
Q1 24
$59.0M
Total Assets
CNTB
CNTB
GPUS
GPUS
Q4 25
$313.7M
Q3 25
$242.4M
Q2 25
$213.5M
Q1 25
$218.5M
Q4 24
$220.8M
Q3 24
$231.5M
Q2 24
$120.6M
$270.8M
Q1 24
$299.8M
Debt / Equity
CNTB
CNTB
GPUS
GPUS
Q4 25
0.69×
Q3 25
1.43×
Q2 25
16.06×
Q1 25
14.71×
Q4 24
11.19×
Q3 24
38.41×
Q2 24
4.00×
Q1 24
0.51×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTB
CNTB
GPUS
GPUS
Operating Cash FlowLast quarter
$-8.0M
$-37.7M
Free Cash FlowOCF − Capex
$-56.2M
FCF MarginFCF / Revenue
-208.7%
Capex IntensityCapex / Revenue
68.6%
Cash ConversionOCF / Net Profit
-0.54×
TTM Free Cash FlowTrailing 4 quarters
$-87.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTB
CNTB
GPUS
GPUS
Q4 25
$-37.7M
Q3 25
$-17.8M
Q2 25
$-3.1M
Q1 25
$-4.0M
Q4 24
$-9.2M
Q3 24
$3.7M
Q2 24
$-8.0M
$-3.7M
Q1 24
$-10.2M
Free Cash Flow
CNTB
CNTB
GPUS
GPUS
Q4 25
$-56.2M
Q3 25
$-20.6M
Q2 25
$-3.5M
Q1 25
$-6.8M
Q4 24
$-9.3M
Q3 24
$2.6M
Q2 24
$-5.9M
Q1 24
$-11.6M
FCF Margin
CNTB
CNTB
GPUS
GPUS
Q4 25
-208.7%
Q3 25
-84.5%
Q2 25
-13.5%
Q1 25
-27.3%
Q4 24
-47.6%
Q3 24
8.4%
Q2 24
-33.4%
Q1 24
-30.3%
Capex Intensity
CNTB
CNTB
GPUS
GPUS
Q4 25
68.6%
Q3 25
11.5%
Q2 25
1.5%
Q1 25
11.5%
Q4 24
0.3%
Q3 24
3.6%
Q2 24
12.6%
Q1 24
3.7%
Cash Conversion
CNTB
CNTB
GPUS
GPUS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.54×
Q1 24
-2.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNTB
CNTB

Segment breakdown not available.

GPUS
GPUS

Transferred Over Time$10.4M39%
Revenue From Mined Crypto Assets At Sentinum Owned And Operated Facilities$5.8M21%
Hotel And Real Estate Operations$4.8M18%
Other$4.0M15%
Turn On Green$2.0M7%

Related Comparisons